Invesco’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
128,772
+85,824
| +200% | +$808K | ﹤0.01% | 2773 |
|
|
2025
Q1 | $233K | Buy |
42,948
+27,291
| +174% | +$148K | ﹤0.01% | 3436 |
|
|
2024
Q4 | $117K | Buy |
15,657
+2,177
| +16% | +$16.2K | ﹤0.01% | 3590 |
|
|
2024
Q3 | $108K | Sell |
13,480
-217
| -2% | -$1.73K | ﹤0.01% | 3595 |
|
|
2024
Q2 | $119K | Sell |
13,697
-238,896
| -95% | -$2.08M | ﹤0.01% | 3713 |
|
|
2024
Q1 | $5.22M | Sell |
252,593
-35,760
| -12% | -$739K | ﹤0.01% | 2210 |
|
|
2023
Q4 | $6.66M | Buy |
+288,353
| New | +$6.66M | ﹤0.01% | 2075 |
|
|
2022
Q2 | – | Sell |
-130,999
| Closed | -$1.59M | – | 4039 |
|
|
2022
Q1 | $1.59M | Sell |
130,999
-6,336
| -5% | -$77K | ﹤0.01% | 2856 |
|
|
2021
Q4 | $1.68M | Sell |
137,335
-33,109
| -19% | -$405K | ﹤0.01% | 2843 |
|
|
2021
Q3 | $1.78M | Buy |
+170,444
| New | +$1.78M | ﹤0.01% | 2846 |
|
|
2019
Q1 | – | Sell |
-2,485
| Closed | -$47K | – | 3685 |
|
|
2018
Q4 | $47K | Buy |
+2,485
| New | +$47K | ﹤0.01% | 3659 |
|
|
2014
Q1 | – | Sell |
-15,080
| Closed | -$599K | – | 4133 |
|
|
2013
Q4 | $599K | Buy |
15,080
+1,756
| +13% | +$69.8K | ﹤0.01% | 3371 |
|
|
2013
Q3 | $548K | Buy |
+13,324
| New | +$548K | ﹤0.01% | 3358 |
|